Dr Den (CMO) interview -- https://www.medscape.c
Post# of 45
(Total Views: 44)
Posted On: 05/02/2025 1:27:06 PM
Dr Den (CMO) interview --
https://www.medscape.com/viewarticle/what-not...25a1000agp
Dr. Robert Den, Chief Medical Officer at Alpha Tau Medical, was recently featured in Medscape in an article on the importance of language and empathy when speaking to patients facing serious illnesses.
Our intratumoral Radium-224 therapy was developed to address an urgent unmet need: a targeted radiotherapeutic which is designed to deliver potent alpha particles directly into tumors, with the goal of maximizing impact and minimizing systemic burden.
Next week, we’ll be sharing this approach at two major international conferences:
ESTRO 2025 in Vienna - advancing the science of precision radiotherapeutics
DDW 2025 in San Diego - highlighting the growing role of endoscopists in pancreatic cancer care
https://www.medscape.com/viewarticle/what-not...25a1000agp
Dr. Robert Den, Chief Medical Officer at Alpha Tau Medical, was recently featured in Medscape in an article on the importance of language and empathy when speaking to patients facing serious illnesses.
Our intratumoral Radium-224 therapy was developed to address an urgent unmet need: a targeted radiotherapeutic which is designed to deliver potent alpha particles directly into tumors, with the goal of maximizing impact and minimizing systemic burden.
Next week, we’ll be sharing this approach at two major international conferences:
ESTRO 2025 in Vienna - advancing the science of precision radiotherapeutics
DDW 2025 in San Diego - highlighting the growing role of endoscopists in pancreatic cancer care
(0)
(0)Alpha Tau Medical Ltd. (DRTS) Stock Research Links
Scroll down for more posts ▼